ORBIMED ADVISORS LLC bought BRVE

August 7, 2026 · Form 4 insider transaction

ORBIMED ADVISORS LLC bought 1,666,667 shares of Braveheart Bio, Inc. at $18.00 per share, a transaction worth $30.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,666,667
Price
$18.00
Total value
$30.00M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 7, 2026
Filing dateAugust 11, 2026
Shares owned after11,901,826
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.; These securities are held of record by OrbiMed Private Investments IX, LP ("OPI IX"). OrbiMed Capital GP IX LLC ("GP IX") is the general partner of OPI IX. OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.; This report on Form 4 is jointly filed by OrbiMed Advisors, GP IX, and Genesis GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated Erez Chimovits, an employee of OrbiMed Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.

View the original Form 4 on SEC EDGAR
ORBIMED ADVISORS LLC bought BRVE: August 7, 2026 | Insider Trading Screener